Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NBPA: a cerebral ischaemic protective agent.

J Zhang1, X Peng, G Wei

  • 1Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China.

Clinical and Experimental Pharmacology & Physiology
|November 5, 1999
PubMed
Summary

3-n-butylphthalide (NBPA), derived from celery, protects brain cells by modulating calcium currents, glutamate release, and energy metabolism. It also influences heat shock protein and c-fos mRNA expression, offering neuroprotection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of differential cross-sections of a single top quark produced in association with a <i>W</i> boson at <math> </math> with ATLAS.

The European physical journal. C, Particles and fields·2019
Same author

Search for the direct production of charginos and neutralinos in final states with tau leptons in <math> </math> <i>pp</i> collisions with the ATLAS detector.

The European physical journal. C, Particles and fields·2019
Same author

Measurement of quarkonium production in proton-lead and proton-proton collisions at <math></math> with the ATLAS detector.

The European physical journal. C, Particles and fields·2019
Same author

Measurement of longitudinal flow decorrelations in Pb+Pb collisions at <math> </math> and 5.02 TeV with the ATLAS detector.

The European physical journal. C, Particles and fields·2019
Same author

Measurement of <math></math> polarisation in <math></math> decays in proton-proton collisions at <math> </math> TeV with the ATLAS detector.

The European physical journal. C, Particles and fields·2019
Same author

Search for dark matter produced in association with bottom or top quarks in <math> </math>  TeV <i>pp</i> collisions with the ATLAS detector.

The European physical journal. C, Particles and fields·2019

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • 3-n-butylphthalide (NBPA) is a derivative of 3-n-butylpathalide isolated from Apium granolens Linn.
  • NBPA's potential therapeutic effects, particularly in neurological conditions, warrant investigation.

Purpose of the Study:

  • To investigate the neuroprotective effects of NBPA.
  • To elucidate the mechanisms underlying NBPA's actions on cellular and molecular pathways relevant to brain injury.

Main Methods:

  • Electrophysiology to assess L-type calcium currents in myocardial and neuroblastoma cells.
  • Measurement of glutamate release from synaptosomes.
  • [31P] nuclear magnetic resonance spectroscopy to evaluate energy metabolism.
  • In situ hybridization to analyze gene expression (HSP70, c-fos).

Related Experiment Videos

  • Assessment of nitric oxide (NO) and nitric oxide synthase (NOS) activity in a rat model of cerebral ischemia-reperfusion.
  • Main Results:

    • NBPA inhibited L-type calcium currents and glutamate release.
    • NBPA improved energy metabolism and modulated the expression of heat shock protein 70 mRNA and c-fos mRNA following cerebral artery occlusion.
    • NBPA reduced nitric oxide levels and NOS activity, and inhibited inducible NOS protein expression in a global cerebral ischemia-reperfusion model.

    Conclusions:

    • NBPA exhibits significant neuroprotective properties.
    • NBPA's mechanisms of action involve the modulation of calcium channels, neurotransmitter release, cellular energy status, gene expression, and the nitric oxide pathway.
    • NBPA demonstrates potential as a therapeutic agent for neurological disorders involving ischemia and excitotoxicity.